Title : Nanodiamond mediated co-delivery of doxorubicin and malaridine to maximize synergistic anti-tumor effects on multi-drug resistant MCF-7/ADR cells.

Pub. Date : 2017 May 21

PMID : 32264289






12 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
2 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
3 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
4 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
5 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
6 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
7 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
8 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
9 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
10 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
11 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus
12 The concentrations of DOX and MAL for (DOX + MAL)@NDs producing 50% growth inhibition were 1.90 and 0.35 mug mL-1, respectively, smaller than the 50% inhibitory concentrations for DOX@NDs and MAL@NDs (10.75 and 4.38 mug mL-1) and for free DOX and free MAL (49.65 and 9.03 mug mL-1). Doxorubicin L1 cell adhesion molecule Mus musculus